학술논문

Cardiac Biomarkers in Youth with Type 2 Diabetes Mellitus: Results from the TODAY Study
Document Type
Academic Journal
Author
Gidding, Samuel S.Bacha, FidaBjornstad, PetterKatz, Lorraine E. LevittLevitsky, Lynne L.Lynch, JaneTryggestad, Jeanie B.Weinstock, Ruth S.El ghormli, LaureLima, Joao A.C.McKay, S.Haymond, M.Anderson, B.Bush, C.Gunn, S.Holden, H.Jones, S. M.Jeha, G.McGirk, S.Thamotharan, S.Cuttler, L.Abrams, E.Casey, T.Dahms, W.Ievers-Landis, C.Kaminski, B.Koontz, M.MacLeish, S.McGuigan, P.Narasimhan, S.Geffner, M.Barraza, V.Chang, N.Conrad, B.Dreimane, D.Estrada, S.Fisher, L.Fleury-Milfort, E.Hernandez, S.Hollen, B.Kaufman, F.Law, E.Mansilla, V.Miller, D.Muñoz, C.Ortiz, R.Ward, A.Wexler, K.Xu, Y. K.Yasuda, P.Katz, Levitt L.Berkowitz, R.Boyd, S.Johnson, B.Kaplan, J.Keating, C.Lassiter, C.Lipman, T.McGinley, G.McKnight, H.Schwartzman, B.Willi, S.Arslanian, S.Bacha, F.Foster, S.Galvin, B.Hannon, T.Kriska, A.Libman, I.Marcus, M.Porter, K.Songer, T.Venditti, E.Goland, R.Gallagher, D.Kringas, P.Leibel, N.Ng, D.Ovalles, M.Seidman, D.Laffel, L.Goebel-Fabbri, A.Hall, M.Higgins, L.Keady, J.Malloy, M.Milaszewski, K.Rasbach, L.Nathan, D. M.Angelescu, A.Bissett, L.Ciccarelli, C.Delahanty, L.Goldman, V.Hardy, O.Larkin, M.Levitsky, L.McEachern, R.Norman, D.Nwosu, D.Park-Bennett, S.Richards, D.Sherry, N.Steiner, B.Tollefsen, S.Carnes, S.Dempsher, D.Flomo, D.Whelan, T.Wolff, B.Weinstock, R.Bowerman, D.Bristol, S.Bulger, J.Hartsig, J.Izquierdo, R.Kearns, J.Saletsky, R.Trief, P.Zeitler, P.Abramson, N.Bradhurst, A.Celona-Jacobs, N.Higgins, J.Kelsey, M.Klingensmith, G.Nadeau, K.Witten, T.Copeland, K.Boss, E.Brown, R.Chadwick, J.Chalmers, L.Chernausek, S.Hebensperger, A.Macha, C.Newgent, R.Nordyke, A.Olson, D.Poulsen, T.Pratt, L.Preske, J.Schanuel, J.Sternlof, S.Lynch, J.Amodei, N.Barajas, R.Cody, C.Hale, D.Hernandez, J.Ibarra, C.Morales, E.Rivera, S.Rupert, G.Wauters, A.White, N.Arbeláez, A.Jones, J.Jones, T.Sadler, M.Tanner, M.Timpson, A.Welch, R.Caprio, S.Grey, M.Guandalini, C.Lavietes, S.Rose, P.Syme, A.Tamborlane, W.Hirst, K.Edelstein, S.Feit, P.Grover, N.Long, C.Pyle, L.Linder, B.Marcovina, S. M.Harting, J.Shepherd, J.Fan, B.Marquez, L.Sherman, M.Wang, J.Nichols, M.Mayer-Davis, E.Liu, Y.Lima, J.Gidding, S.Puccella, J.Ricketts, E.Danis, R.Domalpally, A.Goulding, A.Neill, S.Vargo, P.Wilfley, D.Aldrich-Rasche, D.Franklin, K.Massmann, C.O’Brien, D.Patterson, J.Tibbs, T.Van Buren, D.Palmert, M.Ratner, R.Dremaine, D.Silverstein, J.
Source
The Journal of Pediatrics. Jan 01, 2018 192:86-92e5
Subject
Language
English
ISSN
0022-3476
Abstract
OBJECTIVES: To examine cardiac biomarkers over time in youth-onset type 2 diabetes, and relate serum concentrations to cardiovascular disease risk factors, and left ventricular structure and function. STUDY DESIGN: TODAY (Treatment Options for type 2 Diabetes in Adolescents and Youth) was a multicenter randomized trial of 3 treatments including 521 participants with type 2 diabetes, aged 10-17 years, and with 2-6 years of follow-up. Participants were 36% male, obese, and ethnically diverse. Annual serum concentrations of brain natriuretic peptide, troponin, tumor necrosis factor (TNF)-α, receptors 1 and 2 were related to blood pressure, body mass index, hemoglobin A1c, and left ventricular ejection fraction, diastolic function, relative wall thickness, and mass. RESULTS: Elevated concentrations of brain natriuretic peptide (≥100 pg/mL), TNF-α (≥5.6 pg/mL) and troponin (≥0.01 ng/mL), were present in 17.8%, 18.3%, and 34.2% of the cohort, respectively, at baseline, and in 15.4%, 17.1%, and 31.1% at the end of the study, with wide variability over time, without persistence in individuals or clear relationship to glycemia or cardiovascular structure/function. TNF receptors concentrations were increased at baseline and not significantly different from end-of-study concentrations. Adverse echocardiographic measures were more likely in the highest TNF receptor tertile (all P < .05): higher left ventricular mass (39.3 ± 9.0 g/m), left atrial internal dimension (3.7 ± 0.4 cm) and E/Em ratio, a measure of diastolic dysfunction (6.2 ± 1.9). After adjustment for body mass index, these relationships were no longer significant. CONCLUSIONS: Elevated serum concentrations of cardiac biomarkers were common in youth with type 2 diabetes, but their clinical significance is unclear and will require further long-term study. TRIAL REGISTRATION: ClinicalTrials.gov NCT00081328.